Amlodipine/Valsartan [Design Issues]

posted by Bebac user – Egypt, 2023-09-09 08:34 (570 d 22:24 ago) – Posting: # 23713
Views: 4,064

The combination of Amlodipine and valsartan was published as two periods crossover but after checking the variability of Valsartan, it had more than 30%. Therefore, should I in those cases design this study as replicated or un-replicated ?

Complete thread:

UA Flag
Activity
 Admin contact
23,411 posts in 4,922 threads, 1,666 registered users;
45 visitors (1 registered, 44 guests [including 7 identified bots]).
Forum time: 06:58 CEST (Europe/Vienna)

Statistic – A subject which most statisticians find difficult
but in which nearly all physicians are expert.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5